Sabra Health Care REIT Inc
NASDAQ:SBRA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.91
19.58
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Sabra Health Care REIT Inc
Wall Street
Price Targets
SBRA Price Targets Summary
Sabra Health Care REIT Inc
According to Wall Street analysts, the average 1-year price target for
SBRA
is 19.983 USD
with a low forecast of 18.18 USD and a high forecast of 22.05 USD.
SBRA Last Price Targets
Sabra Health Care REIT Inc
The latest public price target was made on Sep 12, 2024 by
Nicholas Joseph
from
Citigroup
,
who expects
SBRA
stock to
rise by 19%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Nicholas Joseph
Citigroup
|
20
USD
Upside 19% |
3 months ago
Sep 12, 2024
|
Citi Upgrades Sabra Healthcare REIT Inc. (SBRA) to Buy
StreetInsider
|
Michael Lewis
Truist Financial
|
18
USD
Upside 7% |
3 months ago
Sep 3, 2024
|
Sabra Healthcare REIT Inc. (SBRA) PT Raised to $18 at Truist Securities
StreetInsider
|
David Rodgers
Robert W. Baird
|
16
USD
Downside 5% |
6 months ago
Jun 21, 2024
|
Sabra Healthcare REIT Inc. (SBRA) PT Raised to $16 at Baird
StreetInsider
|
Nicholas Yulico
Scotiabank
|
15
USD
Downside 11% |
7 months ago
May 15, 2024
|
Sabra Healthcare REIT Inc. (SBRA) PT Raised to $15 at Scotiabank
StreetInsider
|
Omotayo Okusanya
Credit Suisse
|
13
USD
Downside 23% |
1 year ago
May 31, 2023
|
Wall Street's Most Accurate Analysts Say Hold These 3 Real Estate Stocks Delivering High-Dividend Yields
Benzinga
|
Operating Income
Forecast
Operating Income Estimate
Sabra Health Care REIT Inc
For the last 8 years the
compound annual growth rate for
Sabra Health Care REIT Inc's operating income is
6%.
The projected
CAGR
for the next 4 years is
10%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SBRA's stock price target?
Price Target
19.983
USD
According to Wall Street analysts, the average 1-year price target for
SBRA
is 19.983 USD
with a low forecast of 18.18 USD and a high forecast of 22.05 USD.
What is Sabra Health Care REIT Inc's Revenue forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
Sabra Health Care REIT Inc's revenue is
13%.
The projected
CAGR
for the next 4 years is
8%.
What is Sabra Health Care REIT Inc's Operating Income forecast?
Projected CAGR
10%
For the last 8 years the
compound annual growth rate for
Sabra Health Care REIT Inc's operating income is
6%.
The projected
CAGR
for the next 4 years is
10%.
What is Sabra Health Care REIT Inc's Net Income forecast?
Projected CAGR
136%
For the last 8 years the
compound annual growth rate for
Sabra Health Care REIT Inc's net income is
-18%.
The projected
CAGR
for the next 3 years is
136%.
You don't have any saved screeners yet
